Thomas Fricke Selected Research

transportin SR2

4/2013

The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Fricke Research Topics

Disease

8	Infections 01/2019 - 01/2013
1	Virus Diseases (Viral Diseases) 12/2014
1	HIV Infections (HIV Infection) 01/2012
1	Neoplasms (Cancer) 09/2011

Drug/Important Bio-Agent (IBA)

3	Nuclear Pore Complex Proteins (Nucleoporins)IBA 12/2014 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 12/2014
1	EphA1 Receptor (Eph Receptor)IBA 01/2019
1	Eph Family Receptors (Eph Receptors)IBA 01/2019
1	NucleosidesIBA 01/2017
1	Pharmaceutical PreparationsIBA 12/2014
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	PF-3450074IBA 12/2014
1	Viral DNAIBA 12/2014
1	Antiviral Agents (Antivirals)IBA 12/2014
1	RibonucleoproteinsIBA 12/2014
1	Tripartite Motif ProteinsIBA 01/2014
1	nuclear pore complex protein 98IBA 05/2013
1	Karyopherins (Importin)IBA 04/2013
1	Cleavage And Polyadenylation Specificity FactorIBA 04/2013
1	transportin SR2IBA 04/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013
1	Cell-Penetrating PeptidesIBA 09/2011
1	Arginine (L-Arginine)FDA Link 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	Cytochromes c (Cytochrome c)IBA 09/2011